Back
Nuveen Floating Rate Income Fund Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Buy
67
JFR
Nuveen Floating Rate Income Fund
Last Price:
$7.83
Seasonality Move:
1.19%
Sell
36
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$47.45
Seasonality Move:
-13.46%
Buy
67
Nuveen Floating Rate Income Fund (JFR)
is a Buy
Is Nuveen Floating Rate Income Fund a Buy, Sell or Hold?
-
The current Nuveen Floating Rate Income Fund [JFR] share price is $7.81. The Score for JFR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
JFR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $47.39. The Score for CRNX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JFR Stock Price Chart
What is Nuveen Floating Rate Income Fund's stock price today?
-
The Nuveen Floating Rate Income Fund share price today is $7.81The current trend is relatively stagnant and JFR is experiencing selling pressure, which indicates risk of future bearish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $47.39The current trend is moderately bullish and CRNX is experiencing slight selling pressure.
JFR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.9 | Sell |
| Chaikin Money Flow: | -907531 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 52.21 | Buy |
| Chaikin Money Flow: | -250343 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
JFR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.79 | Buy |
| 20-day SMA: | 7.83 | Sell |
| 50-day SMA: | 7.86 | Sell |
| 200-day SMA: | 8.18 | Sell |
| 8-day EMA: | 7.8 | Buy |
| 20-day EMA: | 7.82 | Sell |
| 50-day EMA: | 7.89 | Sell |
| 200-day EMA: | 8.18 | Sell |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.86 | Sell |
| 20-day SMA: | 47.89 | Sell |
| 50-day SMA: | 44.86 | Buy |
| 200-day SMA: | 35.73 | Buy |
| 8-day EMA: | 47.93 | Sell |
| 20-day EMA: | 47.4 | Sell |
| 50-day EMA: | 45.04 | Buy |
| 200-day EMA: | 39.81 | Buy |
Nuveen Floating Rate Income Fund Earnings Growth & JFR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.27 per share, and an increase next year of $1.67 per share.
Nuveen Floating Rate Income Fund Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||